Patents by Inventor Mahalingam Kannan

Mahalingam Kannan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV protease inhibitors
    Patent number: 7807677
    Abstract: Compounds of the formula I: wherein R1, R2, X and N are as defined in the specification; E is N, CH; A? and A? are terminal groups as defined in the specification. The compounds have utility as HIV-1 protease inhibitors.
    Type: Grant
    Filed: February 9, 2006
    Date of Patent: October 5, 2010
    Assignee: Medivir AB
    Inventors: Jenny Ekegren, Anders Hallberg, Hans Wallberg, Bertil Samuelsson, Mahalingam Kannan
  • Hiv Protease Inhibitors
    Publication number: 20080249102
    Abstract: Compounds of the formula I: wherein R1, R2, X and N are as defined in the specification; E is N, CH; A? and A? are terminal groups as defined in the specification. The compounds have utility as HIV-1 protease inhibitors.
    Type: Application
    Filed: February 9, 2006
    Publication date: October 9, 2008
    Inventors: Jenny Ekegren, Anders Hallberg, Hans Wallberg, Bertil Samuelsson, Mahalingam Kannan